Innovo Research has announced a partnership with agilon health. In addition, four of agilon health's value-based care practice partners are multispecialty practices. The Innovo Research partnership is designed to significantly increase the number of independent physicians participating in clinical trials nationally, which is estimated at only 3%. The new collaboration with agilon health will expand Innovo's nationwide reach with independent physician groups, many of which are positioned as the leading practices in their community. The primary care physicians and specialists on the agilon health platform have embraced value-based care for their senior populations and provide a network that spans across the Southeast, Southwest, Midwest and Northeast regions of the country. Innovo Research will provide these prominent practices with new resources to further engage, educate and support patients in their care through innovative clinical studies. According to the National Institute on Aging, the benefits to patients who participate in clinical trials include playing a more active role in their health care, receiving more frequent health check-ups and having more information on support groups and other resources. Another upside is a higher medication adherence rate and potential cost savings to patients for what can often be expensive pharmaceutical therapies. Innovo Research provides healthcare organizations with a comprehensive and integrated clinical research infrastructure that enables clinical trials to be conducted at the point of patient care. agilon health's physician practices will now be able to offer their patients access to clinical trials that are appropriate and help enhance patient experience and outcomes. Innovo Research is the only clinical research network to offer a high-tech precision data finding program that can be integrated into most EMR systems. The user-friendly analytics tool can be customized for each clinical trial and allows for tracking patients based on age, health conditions, blood type, comorbities, etc. This helps narrow down patients to fit the profile for the study removing that time intensive burden from physicians and their staff. Many clinical trials for pharmaceuticals and medical devices don't get off the ground because of a lack of efficacy; limited funding; the FDA approval process; and problems with recruiting the right patient population. But one of the primary issues affecting the success of clinical trials is physician engagement. Research America reports that 72% of the US population would participate in a clinical trial if their physician recommended it. However, many patients are not informed by their physicians about clinical research opportunities and the benefits of involvement. This results in delayed development of promising new treatments for the millions of patients waiting for much needed medical intervention. Since Innovo Research's inception three years ago, the number of partnering physicians who participate in clinical trials has grown significantly. In fact, physician participation rates in the company's clinical trials are more than six times the national average. And management expects those numbers to grow with the advent of an agilon health partnership.